Victoria Socha

DocwireNews

NFK Spring Clinical Meetings 2021Amy Larkin, PharmD, and Donald Blatherwick of Medscape Education, New York, New York, tested an intervention based on virtual patient simulation (VPS) designed to improve the performance of nephrologists related to identification of patients with, and chronic management of, <a href="https://www.docwirenews.com/nephtimes/nephtimes-diseases-and-conditions/hyperkalemia/neutralize-study-assessing-efficacy-and-safety-of-szc-in-hyperkalemia-and-metabolic-acidosis/">hyperkalemia</a>. Results were reported during a virtual poster session at the NFK Spring Clinical Meetings 2021 in a <a href="https://casehippo.com/spa/symposium/national-kidney-foundation-2021-spring-clinical-meetings/event/gallery/abstracts?abstractId=1724">poster</a> titled Success of Virtual Patient Simulation at Improving Management of Chronic Hyperkalemia.The intervention comprised a patient presenting at two different points in time in a VPS platform allowing learners to order laboratory tests, make diagnoses, and prescribe treatments in a manner designed to match the scope and depth of actual practice. Current evidence and recommendations were used to develop tailored clinical guidance (CG) provided after each decision; the learner was then provided the opportunity to modify decisions. Following the CG, decisions were collected and compared with each user&rsquo;s baseline decisions (pre-CG). P values were determined using a 2-tailed paired t-test, The activity was posted August 30, 2019; initial data were collected through November 7, 2019.At the time of the poster presentation, 40 nephrologists who had completed the activity (completion was defined as providing all decisions within at least one case) were included in the results analysis:Initial visit:<ul>
<li>Diagnosis of CKD stage 32: 3% pre-CG versus 45% post CG; 43% absolute improvement; P&lt;.01</li>
<li>Diagnosis of hyperkalemia: 50% pre-CG versus 70% post-CG; 20% absolute improvement; P&lt;.01</li>
<li>Initiation of a potassium binder: 30% pre-CG versus 73% post-CG; 43% improvement; P&lt;.01</li>
<li>Initiation of a renin-angiotensin-aldosterone (RAAS) inhibitor: 35% pre-CHG versus 73% post-CG; 38% improvement; P&lt;.01</li>
<li>Initiation of a sodium-glucose co-transporter-2 inhibitor or glucagon-like peptide-1 receptor agonist: 78% pre-CG versus 83% post-CG; 5% improvement; P=.16.</li>
</ul>Follow-up visit:<ul>
<li>Initiation of a potassium binder: 28% pre-CG versus 66% post-CG; 38% Improvement; P&lt;.01</li>
<li>Initiation of a loop diuretic: 69% pre-CG versus 97% post-CG; 28% Improvement; P&lt;.01</li>
<li>Initiation of a mineralocorticoid receptor antagonist: 0% pre-CG versus 38% post-CG; 38% improvement; P&lt;.01</li>
<li>Initiation of a RAAS inhibitor: 90% pre-CG versus 93% post-CG; 3% improvement; P=.33</li>
</ul>In conclusion, the authors said, &ldquo;VPS that immerses and engages specialists in an authentic and practical learning experience can improve evidence-based clinical decisions related to patient identification and management of hyperkalemia.&rdquo;Source: Larkin, Blatherwick D. Success of virtual patient simulation at improving management of chronic hyperkalemia. Abstract of a poster presented at the National Kidney Foundation virtual Spring Clinical Meetings 2021 (Abstract #271), April 9, 2021.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

VPS Improves Clinical Decisions Related to Hyperkalemia

Hyperkalemia

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe